• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE¿ LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE¿ LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 385100
Device Problem Leak/Splash (1354)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/06/2018
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that leakage occurred from the bd q-syte¿ luer access split-septum stand-alone device.
 
Manufacturer Narrative
Investigation summary: dhr- review of dhr¿s revealed all required challenge samples, set-up and in process testing was performed in accordance with the quality plans.Review disclosed there was one non-related qn initiated during the build of this lot number 8142530 that would not impact the outcome of the quality of the product relevant to the defect stated in the pir.Received one dispenser with the catalog number 385100, lot number 8148621.Inside of the dispenser were 32 unused q-syte units in sealed packages.Visual/microscopic evaluation: no physical/mechanical damage was observed on any of the external areas of the q-syte units water leak test: the q-syte units were leak test in the actuated and unactuated position; by themselves and attached to the returned extension sets.Leakage was not confirmed in the un-actuate or actuated position during testing.Septum column tear assessment: no damage (cuts/tears) was observed along the column wall.Indeterminate: the defect leakage; could not be identified or confirmed, and cause could not be determined with the representative units returned for investigation.There was no physical/mechanical evidence to confirm and support a manufacturing process related issue for the failures stated in this report.
 
Event Description
It was reported that leakage occurred from the bd q-syte¿ luer access split-septum stand-alone device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE¿ LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MDR Report Key8197777
MDR Text Key131480587
Report Number9610847-2018-00440
Device Sequence Number1
Product Code FPA
UDI-Device Identifier30382903851004
UDI-Public30382903851004
Combination Product (y/n)N
PMA/PMN Number
K013621
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 02/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/26/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date05/31/2023
Device Catalogue Number385100
Device Lot Number8148621
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/20/2018
Date Manufacturer Received12/06/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-